Lidocaine Ointment Market Report 2022: Featuring Glenmark Pharmaceuticals, Novocol Pharma, AstraZeneca & More
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Lidocaine Ointment Market, by Formulation, by Age Group, by Application, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
Topical lidocaine ointment is used on various parts of the body to cause loss of sensation in patients undergoing certain medical procedures, such as surgery. It is also used to relieve pain and itching caused by conditions such as sun burn, poison ivy, poison oak, minor cuts and abrasions. It is also used to prevent and control pain during urethral surgery in both men and women.
Lidocaine is a local anesthetic commonly used for local anesthesia, but it is also used as an antiarrhythmic and analgesic drug and also used as an adjutant to endotracheal intubation. It is a tertiary amine and an antiarrhythmic drug according to the Vaughan-Williams classification. Lidocaine acts as a valuable tool in anesthesiology, cardiology, and pain management. In plasma, lidocaine has 65% of its protein bound to albumin and alpha 1 acid glycoprotein, giving it an intermediate duration of action compared to other local anesthetics. Lidocaine ointment are used to numb the lining of the mouth or throat before certain medical/dental procedures.
Market Dynamics
The increasing research and development activities of lidocaine ointment for product expansion by the key players in the market, which is expected to drive the market growth over the forecast period.
For instance, in January 2021, The Mayo Clinic in Arizona has initiated a clinical study comparing two local anesthetics for fractional non-ablative laser treatment of the face. 2.5 g lidocaine 23%/tetracaine 7% ointment is in Phase 2 and 7.5 g lidocaine 2.5%/prilocaine 2.5% cream is in Phase 3 clinical trials. The scheduled completion date is January 2023.
Key Features of the Study:
This report provides an in-depth analysis of the global lidocaine ointment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global lidocaine ointment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global lidocaine ointment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lidocaine ointment market
Detailed Segmentation:
Global Lidocaine Ointment Market, By Formulation:
Internal Use
Topical Use
Global Lidocaine Ointment Market, By Age Group:
Children
Adult
Global Lidocaine Ointment Market By Application:
Insect Bite
Sun Burn
Minor Cut
Mouth Sore
Others
Global Lidocaine Ointment Market By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Lidocaine Ointment Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Lidocaine Ointment Market- Impact of Coronavirus (Covid-19) Pandemic
5. Global Lidocaine Ointment Market, By Formulation, 2017 - 2030, (US$ Million)
6. Global Lidocaine Ointment Market, By Age Group, 2017 - 2030, (US$ Million)
7. Global Lidocaine Ointment Market, By Application, 2017 - 2030, (US$ Million)
8. Global Lidocaine Ointment Market, By Distribution Channel, 2017 - 2030, (US$ Million
9. Global Lidocaine Ointment Market, By Region, 2017 - 2030, (US$ Million)
10. Competitive Landscape
11. Section
Companies Mentioned
Glenmark Pharmaceuticals U.S. Inc.
Teligent Inc
Taro Pharmaceutical Industries Ltd.
CENTURA PHARMACEUTICALS INC
Neon Laboratories Ltd.
AstraZeneca Canada INC
Novocol Pharma
Amneal Pharmaceuticals LLC.
Alembic Pharmaceuticals Limited
Ascend Laboratories LLC
Liberty Pharmaceuticals, Inc.
Hi-Tech Pharmaceuticals
Aspen Pharmacare Australia Pty Ltd.
Sandoz AG
Zydus Healthcare Limited.
Quagen Pharmaceuticals
Zuche Pharmaceuticals Private Limited.
SEPTODONT, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/5npml1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900